Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry
Gregory Barber, Charles C. Dike
Psychiatric Services (2023) Vol. 74, Iss. 8, pp. 838-846
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Distinctive But Not Exceptional: The Risks of Psychedelic Ethical Exceptionalism
Katherine Cheung, Brian D. Earp, Kyle Patch, et al.
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 16-28
Closed Access | Times Cited: 14
Psychedelic-assisted psychotherapy: where is the psychotherapy research?
Jacob S. Aday, David Horton, Gisele Fernandes‐Osterhold, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1517-1526
Closed Access | Times Cited: 9
Spiritual health practitioners’ contributions to psychedelic assisted therapy: A qualitative analysis
Caroline Peacock, Jennifer S. Mascaro, Erin Brauer, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296071-e0296071
Open Access | Times Cited: 6
Practical considerations in the establishment of psychedelic research programs
Brian S. Barnett, M. Frances Vest, Marcus S. Delatte, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 4
Informed Consent to Psychedelic Medicine
Burton J. Tabaac, Mitchell D. Feldman, Owen S. Muir
American Journal of Therapeutics (2025) Vol. 32, Iss. 1, pp. e37-e39
Closed Access
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper
Marianne Destoop, Pavel Mohr, Florence Butlen-Ducuing, et al.
European Psychiatry (2025) Vol. 68, Iss. 1
Open Access
Peyote: Neurochemistry, Psychological Effects, Cultural Aspects, Religious Perspectives, and Legality
Emma David, H. Russell Searight
(2025), pp. 1-7
Closed Access
Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
Michael J. Lucido, Boadie W. Dunlop
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 161-161
Open Access
Self-treatment with psychedelic substances for health and wellbeing in Aotearoa New Zealand: an exploratory descriptive study
Chris Arnison, Richard Egan, John H. Shaver
Kōtuitui New Zealand Journal of Social Sciences Online (2025), pp. 1-22
Open Access
Exploring Serotonergic Psychedelics as a Treatment for Personality Disorders
Brennan M. Carrithers, Daniel E. Roberts, Brandon Weiss, et al.
Neuropharmacology (2025), pp. 110413-110413
Closed Access
Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis
Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, et al.
The International Journal of Psychiatry in Medicine (2025)
Closed Access
Stutterers’ experiences on classic psychedelics: A preliminary self-report study
Eric S. Jackson, Noam Goldway, Hope Gerlach, et al.
Journal of Fluency Disorders (2024) Vol. 81, pp. 106062-106062
Closed Access | Times Cited: 3
EMBARK Psychedelic Therapy for Depression
Bill Brennan, Alex Belser
(2024)
Closed Access | Times Cited: 2
Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon
Val Bellman
Cancers (2024) Vol. 16, Iss. 9, pp. 1702-1702
Open Access | Times Cited: 2
Psychedelics and the treatment of eating disorders: considerations for future research and practice
Émilie Lacroix, Karsten Fatur, Phillipa Hay, et al.
Journal of Eating Disorders (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia
Samuel P Hatfield, Nicollette Thornton, Kayla Greenstien, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 7, pp. 571-590
Open Access | Times Cited: 1
How to Make Psychedelic-Assisted Therapy Safer
Daniel Villiger
Cambridge Quarterly of Healthcare Ethics (2024), pp. 1-15
Open Access | Times Cited: 1
Ethical Considerations Regarding Psychedelics for Clinical Pain Research
Christopher L. Robinson, Matthew Slitzky, Michael E. Schatman, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 4357-4364
Open Access | Times Cited: 1
Psychedelic-assisted psychotherapy: Where is the psychotherapy research?
Jacob S. Aday, David P Horton, Gisele Fernandes‐Osterhold, et al.
(2023)
Open Access | Times Cited: 3
Introduction to the EMBARK Approach
Bill Brennan, Alex Belser
(2024), pp. 31-69
Closed Access
Preparation Sessions
Bill Brennan, Alex Belser
(2024), pp. 132-166
Closed Access
Bringing It Home and Carrying It Forward
Bill Brennan, Alex Belser
(2024), pp. 253-262
Closed Access
Considerations Prior to Meeting With a Participant
Bill Brennan, Alex Belser
(2024), pp. 93-131
Closed Access
INTRODUCTION: A New Approach for the Whole Person
Bill Brennan, Alex Belser
(2024), pp. 1-9
Closed Access
Choosing Suggested Integration Goals
Bill Brennan, Alex Belser
(2024), pp. 269-269
Closed Access
Page 1 - Next Page

Scroll to top